AR and breast neoplasm: However, recent molecular classifications have identified subsets of breast tumors withhigh androgen receptor expression, including "luminal androgen receptor (LAR) tumors" and "molecular apocrine tumors" (MATs), which mayhave implications for targeted therapies [63].